Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Damora Therapeutics granted equity awards to five newly-hired non-executive employees on October 1, 2026, consisting of options to purchase 144,400 ordinary shares at $21.28 per share with a 10-year term. The inducement grants were approved by the Compensation Committee as material incentives for employment acceptance.